IL2 and neoplasm: CTLs activated by derived from tumor-associated antigen HLA-restricted epitopes play a key role in specifically killing cancer cells through directly lysing tumor cells and secrete cytokines such as IFN-γ, TNF-α, and IL-2 [17, 33].